Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States

NCT01873417 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
237
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen